Mithril Capital Management

Founded 2012
Founders Ajay Gopal Royan Peter Thiel

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 41
Average round size
info
The average size of a deal this fund participated in
$83M
Portfolio companies 27
Rounds per year 4.56
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.34
Exits 5
Key employees 6
Stages of investment
Late Stage Venture
Seed

Areas of investment

  • Enterprise Software
  • Software
  • Health Care
  • Biotechnology
  • Medical Device
Summary

Mithril Capital Management is the famous VC, which was founded in 2012. The main department of described VC is located in the San Francisco. The venture was found in North America in United States.

The top activity for fund was in 2014. Deals in the range of 50 - 100 millions dollars are the general things for fund. Comparing to the other companies, this Mithril Capital Management performs on 20 percentage points less the average number of lead investments. The top amount of exits for fund were in 2019. The typical startup value when the investment from Mithril Capital Management is more than 1 billion dollars. Considering the real fund results, this VC is 27 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year.

The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biotechnology, SaaS. Among the most popular portfolio startups of the fund, we may highlight Palantir Technologies, Auris Health, Inc., AppDirect.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Mithril Capital Management, startups are often financed by Desmarais Group, Accel, iNovia Capital. The meaningful sponsors for the fund in investment in the same round are Lux Capital, Bessemer Venture Partners, Union Square Ventures. In the next rounds fund is usually obtained by Bessemer Venture Partners, Temasek Holdings, Union Square Ventures.

This organization was formed by Ajay Gopal Royan, Peter Thiel. Besides them, we counted 6 critical employees of this fund in our database.

Read more

Funds with similar focus

Funds from United States, San Francisco
Funds with similar focus located in United States, San Francisco:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CDP Capital Technology Ventures Canada, Montréal
Social Impact Capital United States, New York
Chivas Venture United Kingdom, London
hiCenter Ventures Israel, Hefa
LAF China, Shantou
Early Stage Enterprises United States, Princeton
Sunsea China, Shenzhen
Pontos Group Finland, Helsinki
Mannai Corporation Qatar, Doha
RATP Group France, Paris
AAS Technologies United States, Hackensack
J.P. Morgan Cazenove United Kingdom, London
Sony Music Entertainment Japan Japan, Chiyoda
Bladex Panama, Panama City
Techstars Autonomous Technology United States, Boston
T Investment -
P1 Ventures -
Ningbo Puhui Qiye Guanli China, Ningbo
Skylake Capital -
The Ballast Fund United States, Edwards

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Paxos

Blockchain
Cryptocurrency
Finance
Financial Services
FinTech
1
$300M29 Apr 2021 United States, New York

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$336M19 Apr 2021 United States, " United States"}

Flex Logix Technologies

Artificial Intelligence
Information Technology
Semiconductor
Software
1
$55M22 Mar 2021 United States, Mountain View

ForSight Robotics

Health Care
Medical
Medical Device
Robotics
1
$10M09 Mar 2021 Israel, " Israel"}

Glance

Artificial Intelligence
Internet
Mobile
Mobile Apps
Personalization
1
$145M22 Dec 2020 Singapore, Singapore

Paxos

Blockchain
Cryptocurrency
Finance
Financial Services
FinTech
1
$142M16 Dec 2020 United States, New York

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$80M10 Nov 2020 United States, " United States"}

Neocis

Dental
Health Care
Medical Device
Robotics
1
$72M08 Oct 2020 United States, Miami

Treasure Card

Debit Cards
EdTech
Education
1
$3M25 Sep 2020 Canada, Toronto
News
Paxos raises $300 million to build a cryptocurrency infrastructure giant

– Paxos has raised $300m funding.
– The round was led by Oak HC/FT and joined by Declaration Partners, PayPal Ventures, Mithril Capital, Senator Investment Group, Liberty City Ventures and WestCap.
– Paxos offers different products, such as crypto trading and settlement, custody and the ability to issue tokens.
– It focuses on big enterprise clients, such as Revolut, Crédit Suisse, Société Générale and StoneX.
– The company tries to be as compliant as possible. And it plans to remain committed to regulation across several geographies and verticals.

Adagio Therapeutics Announces $336 Million Series C Financing to Support Rapid Advancement of Novel ADG20 Antibody for the Treatment and Prevention of COVID-19

– Adagio Therapeutics, Inc., a biotechnology company developing best-in-class antibodies to broadly neutralize coronaviruses, today announced the completion of a $336m Series C financing led by RA Capital Management, with participation from new investors, including Redmile Group, Federated Hermes, Foresite Capital, ArrowMark Partners, PremjiInvest, and another leading healthcare investor.
– Existing investors Fidelity Management & Research Company, LLC, OrbiMed, Polaris Partners, Mithril, GV, Population Health Partners, Adimab and Omega Funds also participated in the financing.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mithril Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: